Attleboro, MA, United States of America

Russell Francis Durgin

This inventor holds 67 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 2 EPO patents, primarily in Endoscopic Devices (CPC class A61B). Top assignees: Boston Scientific Scimed, Inc., Scimed Life Systems, Inc., Ovesco Endoscopy, Gmbh. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Russell Francis Durgin. Retrieved from https://idiyas.com/inventor/russell-francis-durgin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 67 

% Patents Active = 65.7

 


Average Co-Inventor Count = 3.4

ph-index = 23

Forward Citations = 3,172(Granted Patents)

Forward Citations (Not Self Cited) = 3,014(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • (2017)
  • Attleboro, MA (US) (2001 - 2018)
  • Bellingham, MA (US) (2014 - 2024)

Company Filing History:


Years Active: 2001-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Hemostatic Clipping
Tension Member Release Clip
Endoscopic Instruments
Endoluminal Access Devices
Single Stage Hemostasis
Catheter Design
Transluminal Surgery Kit
Electro-Cautery Catheter
Distal Chamber
Pyloric Obesity Valve
67 patents (USPTO):Explore Patents

Title: Russell Francis Durgin: A Pioneer in Hemostatic Clipping Devices

Introduction

Russell Francis Durgin, based in Attleboro, MA, is a notable inventor known for his contributions to the field of medical devices, specifically in the area of hemostatic clipping technology. With a remarkable total of 64 patents under his name, Durgin has significantly advanced the capabilities of tissue clipping apparatuses, paving the way for innovative solutions in surgical procedures.

Latest Patents

Among his latest innovations are patents for hemostatic clipping devices and methods. These patents describe a sophisticated tissue clipping apparatus that consists of a flexible, elongate member. The design allows a user to operate the proximal end externally while the distal end is inserted into the body near the target tissue. The apparatus features a control wire that extends through the flexible member, in combination with a capsule that is releasably coupled to the distal end. A clip, housed within the capsule, has a proximal portion that fits into the device. This inventive device includes a joint that couples the clip to the control wire, featuring a yoke around the proximal end of the clip and a frangible link that separates the clip from the control wire when a predetermined force is applied, ensuring precision and safety in surgical procedures.

Career Highlights

Durgin has held significant positions in prominent companies, including Boston Scientific Scimed, Inc. and Scimed Life Systems, Inc., where he has been instrumental in developing cutting-edge medical technologies. His expertise and innovative mindset have made him a key figure in the creation of devices that enhance surgical efficiency and patient safety.

Collaborations

Throughout his career, Russell Durgin has collaborated with notable engineers and inventors such as William C. Mers Kelly and Gregory R. Furnish. These partnerships have been vital in bringing forth innovative ideas and turning them into practical solutions in the medical device industry.

Conclusion

Russell Francis Durgin's extensive portfolio of 64 patents exemplifies his dedication to innovation in medical technology. Through his work on hemostatic clipping devices, he has made a lasting impact on surgical practices, contributing to improved outcomes for patients and advancements in medical procedures. His collaborations and career accomplishments illustrate the importance of teamwork and creativity in driving innovation forward.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…